Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers

This study aimed to compare common histologic markers at the invasive front of colon adenocarcinoma in terms of prognostic accuracy and interobserver agreement. Consecutive patients who underwent curative resection for stages I to III colon adenocarcinoma at a single institution in 2007 to 2014 were identified. Poorly differentiated clusters (PDCs), tumor budding, perineural invasion, desmoplastic reaction, and Crohn-like lymphoid reaction at the invasive front, as well as the World Health Organization (WHO) grade of the entire tumor, were analyzed. Prognostic accuracies for recurrence-free survival (RFS) were compared, and interobserver agreement among 3 pathologists was assessed. The study cohort consisted of 851 patients. Although all the histologic markers except WHO grade were significantly associated with RFS (PDCs, tumor budding, perineural invasion, and desmoplastic reaction: P<0.001; Crohn-like lymphoid reaction: P=0.021), PDCs (grade 1 [G1]: n=581; G2: n=145; G3: n=125) showed the largest separation of 3-year RFS in the full cohort (G1: 94.1%; G3: 63.7%; hazard ratio [HR], 6.39; 95% confidence interval [CI], 4.11-9.95; P<0.001), stage II patients (G1: 94.0%; G3: 67.3%; HR, 4.15; 95% CI, 1.96-8.82; P<0.001), and stage III patients (G1: 89.0%; G3: 59.4%; HR, 4.50; 95% CI, 2.41-8.41; P<0.001). PDCs had the highest prognostic accuracy for RFS with the concordance probability estimate of 0.642, whereas WHO grade had the lowest. Interobserver agreement was the highest for PDCs, with a weighted kappa of 0.824. The risk of recurrence over time peaked earlier for worse PDCs grade. Our findings indicate that PDCs are the best invasive-front histologic marker in terms of prognostic accuracy and interobserver agreement. PDCs may replace WHO grade as a prognostic indicator.

[1]  Phil Quirke,et al.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 , 2017, Modern Pathology.

[2]  V. Barresi,et al.  Poorly Differentiated Clusters: Clinical Impact in Colorectal Cancer , 2017, Clinical colorectal cancer.

[3]  Stephen B Gruber,et al.  Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer. , 2016, Journal of the National Cancer Institute.

[4]  T. Kawasaki,et al.  Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer: A Retrospective Study at Two Institutions , 2016, Annals of Surgical Oncology.

[5]  Y. Ajioka,et al.  Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer , 2016, Diseases of the colon and rectum.

[6]  S. Bettelli,et al.  Poorly differentiated clusters (PDC) in colorectal cancer: what is and ought to be known , 2016, Diagnostic Pathology.

[7]  L. Reggiani Bonetti,et al.  Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinous adenocarcinoma. , 2015, Human pathology.

[8]  E. Andersson,et al.  Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome. , 2015, Translational research : the journal of laboratory and clinical medicine.

[9]  Tetsuo Nemoto,et al.  A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study , 2015, Modern Pathology.

[10]  H. Ueno,et al.  Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis. , 2015, Surgery.

[11]  Hideki Ueno,et al.  Histologic Categorization of Desmoplastic Reaction: Its Relevance to the Colorectal Cancer Microenvironment and Prognosis , 2015, Annals of Surgical Oncology.

[12]  Y. Ajioka,et al.  Clinical significance of perineural invasion diagnosed by immunohistochemistry with anti-S100 antibody in Stage I-III colorectal cancer , 2014, Surgery Today.

[13]  N. Cho,et al.  Comparative validation of assessment criteria for Crohn-like lymphoid reaction in colorectal carcinoma , 2014, Journal of Clinical Pathology.

[14]  H. Ueno,et al.  Prognostic impact of histological categorisation of epithelial–mesenchymal transition in colorectal cancer , 2014, British Journal of Cancer.

[15]  H. Ueno,et al.  Site-specific Tumor Grading System in Colorectal Cancer: Multicenter Pathologic Review of the Value of Quantifying Poorly Differentiated Clusters , 2014, The American journal of surgical pathology.

[16]  J. Meyerhardt,et al.  Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  H. Ueno,et al.  Characterization of Perineural Invasion As a Component of Colorectal Cancer Staging , 2013, The American journal of surgical pathology.

[18]  H. Ueno,et al.  Objective criteria for crohn-like lymphoid reaction in colorectal cancer. , 2013, American journal of clinical pathology.

[19]  R. Labianca,et al.  ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  H. Ueno,et al.  Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy , 2012, Histopathology.

[21]  E. Diamandis,et al.  Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue , 2012, Molecular Cancer Research.

[22]  C. Ratto,et al.  Potential pitfalls concerning colorectal cancer classification in the seventh edition of the AJCC Cancer Staging Manual. , 2011, Diseases of the colon and rectum.

[23]  Matthijs J. Warrens,et al.  Inequalities between multi-rater kappas , 2010, Adv. Data Anal. Classif..

[24]  R. Weinberg,et al.  Tumor-host interactions: a far-reaching relationship. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  I. Zlobec,et al.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. , 2009, World journal of gastroenterology.

[26]  L. Terracciano,et al.  CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer , 2009, British Journal of Cancer.

[27]  K. Hatakeyama,et al.  Multiple-sectioning Study to Establish a Standardized Immunohistochemical Method for Detecting Isolated Tumor Cells in Lymph Nodes of Patients with Colorectal Cancer , 2008 .

[28]  Mithat Gonen,et al.  Individualized prediction of colon cancer recurrence using a nomogram. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  L. Terracciano,et al.  Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer , 2007, The Journal of pathology.

[30]  F. Prall.  Tumour budding in colorectal carcinoma , 2007, Histopathology.

[31]  G. Berx,et al.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. , 2006, Gastroenterology.

[32]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[33]  M. Gonen,et al.  Concordance probability and discriminatory power in proportional hazards regression , 2005 .

[34]  H. Ueno,et al.  A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo‐fragments around budding foci , 2005, Histopathology.

[35]  M. Somerfield,et al.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Hidetaka Mochizuki,et al.  Risk factors for an adverse outcome in early invasive colorectal carcinoma. , 2004, Gastroenterology.

[37]  W. Gerald,et al.  Value of Histopathology in Predicting Microsatellite Instability in Hereditary Nonpolyposis Colorectal Cancer and Sporadic Colorectal Cancer , 2003, The American journal of surgical pathology.

[38]  M E Hammond,et al.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.

[39]  Carolyn Compton,et al.  American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.

[40]  K R Hess,et al.  Hazard function estimators: a simulation study. , 1999, Statistics in medicine.

[41]  H. Müller,et al.  Hazard rate estimation under random censoring with varying kernels and bandwidths. , 1994, Biometrics.

[42]  Jacob Cohen,et al.  The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of Reliability , 1973 .

[43]  R. Light.  Measures of response agreement for qualitative data: Some generalizations and alternatives. , 1971 .

[44]  L. Sobin,et al.  Protocol for the Examination of Specimens from Patients with Primary Carcinoma of the Colon and Rectum Well-differentiated neuroendocrine neoplasms , 2009 .

[45]  J. Boyd,et al.  Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. , 2008, Human pathology.